Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 36.09% is in line with its 5-year average of 33.49%, near the high end of its 5-year range (-10.72%–50.90%).
As of the fiscal period ended Sunday, March 29, 2026. 0.80% above its 12-month average of 35.80%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
36.09%
EBITDA MARGIN AVG TTM
35.80%
EBITDA MARGIN AVG 3Y
36.65%
EBITDA MARGIN AVG 5Y
37.43%
EBITDA MARGIN AVG 10Y
37.52%
EBITDA MARGIN AVG 15Y
37.82%
EBITDA MARGIN AVG 20Y
36.70%
CURRENT VS TTM AVG
+0.80%
CURRENT VS 3Y AVG
-1.53%
CURRENT VS 5Y AVG
-3.59%
CURRENT VS 10Y AVG
-3.81%
CURRENT VS 15Y AVG
-4.59%
CURRENT VS 20Y AVG
-1.68%
Market Cap
$134.62B
EBITDA Margin
30.87%
TTM Avg
31.21%
3Y Avg
32.47%
5Y Avg
31.98%
Market Cap
$126.79B
EBITDA Margin
34.35%
TTM Avg
37.11%
3Y Avg
39.27%
5Y Avg
39.28%
Market Cap
$126.60B
EBITDA Margin
24.22%
TTM Avg
25.63%
3Y Avg
25.70%
5Y Avg
26.23%
Market Cap
$121.16B
EBITDA Margin
41.14%
TTM Avg
20.45%
3Y Avg
32.86%
5Y Avg
36.27%
Market Cap
$119.53B
EBITDA Margin
35.99%
TTM Avg
34.83%
3Y Avg
32.83%
5Y Avg
33.22%
Market Cap
$160.55B
EBITDA Margin
49.12%
TTM Avg
32.26%
3Y Avg
34.27%
5Y Avg
33.90%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pfizer Inc. (PFE) | $139.86B | 36.09% | 35.80% | 36.65% | 37.43% |
| CVS Health Corp. (CVS)vs › | $137.47B | 3.73% | 3.63% | 4.02% | 4.83% |
| Danaher Corporation (DHR)vs › | $134.62B | 30.87% | 31.21% | 32.47% | 31.98% |
| Bristol-Myers Squibb Company (BMY)vs › | $126.79B | 34.35% | 37.11% | 39.27% | 39.28% |
| Stryker Corporation (SYK)vs › | $126.60B | 24.22% | 25.63% | 25.70% | 26.23% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $121.16B | 41.14% | 20.45% | 32.86% | 36.27% |
| Intuitive Surgical, Inc. (ISRG)vs › | $119.53B | 35.99% | 34.83% | 32.83% | 33.22% |
| Gilead Sciences, Inc. (GILD)vs › | $160.55B | 49.12% | 32.26% | 34.27% | 33.90% |
| Medtronic plc (MDT)vs › | $106.51B | 25.92% | 26.11% | 25.62% | 25.51% |
| GSK plc (GSK)vs › | $103.60B | 32.61% | 26.78% | 28.16% | 28.64% |
Gross Margin
69.3%
EBITDA Margin
36.1%
Operating Margin
23.4%
Net Margin
11.8%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-03-29 | 36.09% |
| 2025-12-31 | 30.61% |
| 2025-09-28 | 31.30% |
| 2025-06-29 | 35.49% |
| 2025-03-30 | 45.51% |
| 2024-12-31 | 42.31% |
| 2024-09-29 | 37.98% |
| 2024-06-30 | 27.18% |
| 2024-03-31 | 42.31% |
| 2023-12-31 | 2.79% |
| 2023-10-01 | -10.72% |
| 2023-07-02 | 30.17% |
| 2023-04-02 | 44.21% |
| 2022-12-31 | 28.27% |
| 2022-10-02 | 48.07% |
| 2022-07-03 | 50.90% |
| 2022-04-03 | 43.76% |
| 2021-12-31 | 19.12% |
| 2021-10-03 | 37.82% |
| 2021-07-04 | 38.61% |
| 2021-04-04 | 41.46% |
| 2020-12-31 | 17.44% |
| 2020-09-27 | 36.08% |
| 2020-06-28 | 37.61% |
| 2020-03-29 | 42.35% |
| 2019-12-31 | 27.02% |
| 2019-09-29 | 38.82% |
| 2019-06-30 | 43.21% |
| 2019-03-31 | 46.07% |
| 2018-12-31 | 35.03% |
| 2018-09-30 | 41.43% |
| 2018-07-01 | 41.77% |
| 2018-04-01 | 43.51% |
| 2017-12-31 | 29.61% |
| 2017-10-01 | 41.37% |
| 2017-07-02 | 42.24% |
| 2017-04-02 | 44.66% |
| 2016-12-31 | 30.06% |
| 2016-10-02 | 38.88% |
| 2016-07-03 | 36.16% |
| 2016-04-03 | 38.74% |
| 2015-12-31 | 23.07% |
| 2015-09-27 | 40.34% |
| 2015-06-28 | 38.41% |
| 2015-03-29 | 35.78% |
| 2014-12-31 | 24.58% |
| 2014-09-28 | 37.50% |
| 2014-06-29 | 39.40% |
| 2014-03-30 | 33.48% |
| 2013-12-31 | 35.41% |
| 2013-09-29 | 42.19% |
| 2013-06-30 | 41.29% |
| 2013-03-31 | 40.47% |
| 2012-12-31 | 32.82% |
| 2012-09-30 | 39.23% |
| 2012-07-01 | 44.03% |
| 2012-04-01 | 40.42% |
| 2011-12-31 | 34.01% |
| 2011-10-02 | 37.69% |
| 2011-07-03 | 34.40% |
| 2011-04-03 | 34.79% |
| 2010-12-31 | 24.78% |
| 2010-10-03 | 21.17% |
| 2010-07-04 | 37.73% |
| 2010-04-04 | 32.05% |
| 2009-12-31 | 31.45% |
| 2009-09-27 | 42.32% |
| 2009-06-28 | 37.90% |
| 2009-03-29 | 44.89% |
| 2008-12-31 | 42.46% |
| 2008-09-28 | 31.04% |
| 2008-06-29 | 32.47% |
| 2008-03-30 | 40.67% |
| 2007-12-31 | 28.69% |
| 2007-09-30 | 18.37% |
| 2007-07-01 | 32.70% |
| 2007-04-01 | 48.24% |
| 2006-12-31 | 30.66% |
| 2006-10-01 | 42.34% |
| 2006-07-02 | 41.29% |
| 2006-04-02 | 45.91% |
| 2005-12-31 | 37.31% |
| 2005-10-02 | 41.82% |
| 2005-07-03 | 38.58% |
| 2005-04-03 | 42.28% |
| 2004-12-31 | 40.25% |
| 2004-09-26 | 44.34% |
| 2004-06-27 | 39.69% |
| 2004-03-28 | 51.03% |
| 2003-12-31 | 32.08% |
| 2003-09-28 | 29.68% |
| 2003-06-29 | 28.46% |
| 2003-03-30 | 44.14% |
| 2002-12-31 | 49.29% |
| 2002-09-29 | 39.81% |
| 2002-06-30 | 35.40% |
